Literature DB >> 10192768

Synoretin--A new protein belonging to the synuclein family.

A Surguchov1, I Surgucheva, E Solessio, W Baehr.   

Abstract

Aoffa-Synuclein, a presynaptic nerve terminal protein, may be an important component of Lewy bodies in Parkinson's disease, dementia with Lewy bodies, and other neurodegenerative diseases. Additionally, recent genetic studies based on linkage analysis and cosegregation of A53T and A30P missense mutations demonstrated that the alpha-synuclein gene may be responsible for the development of at least some cases of familial Parkinson's disease. Despite intense interest in the members of the synuclein family, their function(s) and exact role in the diseases remained unknown. Here we describe a new member of the synuclein family, which we term synoretin, and show that it is expressed in different retinal cells, as well as in the brain, and it may affect the regulation of signal transduction through activation of the Elk1 pathway. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192768     DOI: 10.1006/mcne.1999.0735

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  16 in total

1.  alpha-synuclein promotes mitochondrial deficit and oxidative stress.

Authors:  L J Hsu; Y Sagara; A Arroyo; E Rockenstein; A Sisk; M Mallory; J Wong; T Takenouchi; M Hashimoto; E Masliah
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.

Authors:  Sreeganga Chandra; Francesco Fornai; Hyung-Bae Kwon; Umar Yazdani; Deniz Atasoy; Xinran Liu; Robert E Hammer; Giuseppe Battaglia; Dwight C German; Pablo E Castillo; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

Review 3.  Persistent remodeling and neurodegeneration in late-stage retinal degeneration.

Authors:  Rebecca L Pfeiffer; Robert E Marc; Bryan William Jones
Journal:  Prog Retin Eye Res       Date:  2019-07-26       Impact factor: 21.198

4.  Expression and subcellular location of alpha-synuclein during mouse-embryonic development.

Authors:  Shan-chuan Zhong; Xue Luo; Xing-shu Chen; Qi-yan Cai; Jing Liu; Xing-hua Chen; Zhong-xiang Yao
Journal:  Cell Mol Neurobiol       Date:  2009-11-03       Impact factor: 5.046

5.  Regulation of Weibel-Palade body exocytosis by alpha-synuclein in endothelial cells.

Authors:  Kwang Soo Kim; Ji-Young Park; Ilo Jou; Sang Myun Park
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

6.  Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons.

Authors:  D D Murphy; S M Rueter; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 7.  Pathological proteins in Parkinson's disease: focus on the proteasome.

Authors:  Heather Snyder; Benjamin Wolozin
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.

Authors:  Dharmin Rokad; Shivani Ghaisas; Dilshan S Harischandra; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Brain Res Bull       Date:  2016-12-16       Impact factor: 4.077

9.  Porcine gamma-synuclein: molecular cloning, expression analysis, chromosomal localization and functional expression.

Authors:  Pernille Munk Frandsen; Lone Bruhn Madsen; Christian Bendixen; Knud Larsen
Journal:  Mol Biol Rep       Date:  2008-05-07       Impact factor: 2.316

10.  Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Authors:  Manfred Windisch; Birgit Hutter-Paier; Edward Rockenstein; Makoto Hashimoto; Margaret Mallory; Eliezer Masliah
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.